Table 1 RT–qPCR testing results on nasal and oral swabs of the dogs and serology

From: Infection of dogs with SARS-CoV-2

 

TLVL laboratory

HKU laboratory

Ct (E)

Ct (RdRp)

Ct (nsp14)

Ct (N)

Ct (nsp16)

Ct (M)

Serum PRNT90 titre

 

Date of collection

Nasal

Oral

Nasal

Oral

Nasal

Oral

Nasal

N gene copies per ml (nasal)

Oral

Nasal

Oral

Nasal

Oral

 

Dog 1 (potential exposure 12–26 Feb)

26 Feb

33.90

34.52

38.97

Neg.

36.76

37.96

34.71

11,741

36.48

37.94

39.25

36.91

37.95

 

28 Feb

31.98

Neg.

37.44

Neg.

38.96

39.01

34.58

10,145

Neg.

38.64

Neg.

38.97

Neg.

 

2 Mar

31.69

Neg.

Neg.

Neg.

32.49

Neg.

33.2

25,788

Neg.

32.71

Neg.

32.41

Neg.

 

3 Mar

             

1:80

5 Mar

33.58

Neg.

38.53

Neg.

39.14

Neg.

38.43

751

Neg.

37.72

Neg.

Neg.

Neg.

 

9 Mar

30.07

Neg.

Neg.

Neg.

35.86

Neg.

34.97

7,777

Neg.

36.96

Neg.

36.24

Neg.

 

12 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

 

13 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

 

Dog 2 (potential exposure 10–17 Mar)

18 Mar

24.85

26.60

31.19

32.63

26.74

28.72

27.31

724,500

29.33

28.26

30.29

27.73

29.49

 

19 Mar

28.11

31.23

36.12

38.45

32.98

36.09

32.66

62,933

36.98

33.65

36.95

32.17

35.97

<1:10

20 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

 

23 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

1:40

24 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

 

30 Mar

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

Neg.

1:160

Cut-off Ct for positive

<36

<36

<39

<39

<40

<40

<40

<40

<40

<40

<40

<40

<40

 
  1. The E, nsp14 and N RT–qPCR assays are cross-reactive with SARS-CoV-2, SARS-CoV and closely related bat-SARS CoV viruses. The RdRp, nsp16 and M RT–qPCR assays are specific for SARS-CoV-2. Gene copies per millilitre of original swab specimen with adjustment for virus extraction dilutions. Assumes no pre-symptomatic shedding of virus from human cases. Neg., negative.